Your browser doesn't support javascript.
Supporting syringe services programs in the initiation and scale-up of vaccine administration: findings from in-depth interviews.
Carry, Monique; Bixler, Danae; Weng, Mark K; Doshani, Mona; Roberts, Emma; Montgomery, Martha P.
  • Carry M; Division of Global HIV & TB, Centers for Disease Control and Prevention, 1600 Clifton Road, Atlanta, GA, 30329, USA. kju8@cdc.gov.
  • Bixler D; Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA.
  • Weng MK; Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA.
  • Doshani M; Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA.
  • Roberts E; National Harm Reduction Coalition, 243 5th Ave., PO Box 529, New York, NY, 10016, USA.
  • Montgomery MP; Division of Viral Hepatitis, Centers for Disease Control and Prevention, 1600 Clifton Rd, Atlanta, GA, 30329, USA.
Harm Reduct J ; 19(1): 100, 2022 09 01.
Article in English | MEDLINE | ID: covidwho-2009413
ABSTRACT

BACKGROUND:

Vaccine-hesitant persons who inject drugs are at increased risk for several vaccine-preventable diseases. However, vaccination rates among this population remain low. While syringe services programs (SSPs) are places where persons who inject drugs feel comfortable accessing services, few offer vaccination services. This study describes facilitators and barriers to vaccination at SSPs.

METHODS:

We used convenience sampling to conduct semi-structured, qualitative in-depth interviews with 21 SSPs in the USA from June to August 2021. Interview questions asked SSPs about their perceptions, priorities, barriers, facilitators, and the effects of partnerships and policies on vaccine administration. We used deductive thematic analysis to identify the main themes.

RESULTS:

Eight (n = 8) SSPs offered vaccinations, and thirteen (n = 13) did not offer vaccinations. Most SSPs believed offering vaccination services was important, although addressing SSP participants' immediate needs often took precedence. Staffing, physical space, and logistical issues were the most common barriers to vaccine administration reported by SSPs, followed by SSP participant-related barriers. Facilitators of vaccine administration included access to a tracking system, partnering with agencies or other organizations providing vaccines, and having a licensed vaccination provider on-site. Partnerships provided SSPs opportunities to expand capacity but could also restrict how SSPs operate. Recommended policy changes to facilitate vaccine administration included subsidizing the cost of vaccinations and addressing restrictions around who could administer vaccinations.

CONCLUSIONS:

Increasing the availability of vaccination services at SSPs requires addressing the varying capacity needs of SSPs, such as tracking systems, licensed vaccinators, and free or low-cost vaccination supplies. While these needs can be met through partnerships and supportive policies, both must consider and reflect cultural competence around the lived experiences of persons who inject drugs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Substance Abuse, Intravenous / Drug Users Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: Harm Reduct J Year: 2022 Document Type: Article Affiliation country: S12954-022-00681-x

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / Substance Abuse, Intravenous / Drug Users Type of study: Observational study / Prognostic study / Qualitative research Topics: Vaccines Limits: Humans Language: English Journal: Harm Reduct J Year: 2022 Document Type: Article Affiliation country: S12954-022-00681-x